Crizalk 200 mg Capsule
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Crizalk 200 mg Capsule

Crizalk 200 mg Capsule

Crizalk 200 mg Capsule contains crizotinib, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It works by blocking abnormal ALK and ROS1 signaling that can promote cancer cell growth. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Crizalk 200 mg Capsule contains 200 mg of crizotinib and is supplied as a hard gelatin capsule for oral administration. It is indicated for advanced non-small cell lung cancer with specific ALK or ROS1 alterations. The capsule may be taken with or without food and should be swallowed whole with water. Treatment should be prescribed and monitored by an experienced oncology specialist.

Technical Specification

Specification Details
Active Ingredient Crizotinib 200 mg
Dosage Form Hard Capsule
Therapeutic Class Tyrosine Kinase Inhibitor
Main Indication Non-Small Cell Lung Cancer
Molecular Targets ALK and ROS1
Route of Administration Oral

Product Also Known As

Crizalk 200 mg Capsule, Crizalk Crizotinib 200 mg Capsule, Crizotinib 200 mg Capsule, Crizotinib Hard Capsule, Crizotinib Lung Cancer Capsule, Crizotinib ALK Inhibitor Capsule